SCHWARZ PHARMA Unveils Positive Phase III Data On Lacosamide At North American Regional Epilepsy Congress In San Diego
Tue, 05 Dec 2006 08:00 AM EST
... For the first time at the North American Regional Epilepsy Congress, SCHWARZ PHARMA presented results from one of its Phase III trials, which investigated the efficacy and safety of oral lacosamide as adjunctive therapy in adults with uncontrolled partial seizures. [click link for full article] ...
Related Topics
- Epilepsy
- American Indian
- Data & Statistics
- Data Analysis
- Visitors Center
- National Data
- Retinopathy of Prematurity
- Air Pollution
- Antithrombin III
- American Ginseng
- Hypnotherapy
- Elder Abuse
- Complex Regional Pain Syndrome
- Anesthesia
- Liposuction
- Chiropractic
- Cosmetic Dentistry
- Asian American
- American Sign Language
- Familial Dysautonomia

Not Signed In -


